MariMed Inc. (OTCMKTS:MRMD) Short Interest Down 75.0% in June

MariMed Inc. (OTCMKTS:MRMD) saw a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 16,030 shares, a decrease of 75.0% from the May 31st total of 64,138 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 1,406,144 shares, the short-interest ratio is presently 0.0 days.

MariMed Price Performance

MariMed stock traded up $0.00 during mid-day trading on Monday, hitting $0.07. 150,730 shares of the company traded hands, compared to its average volume of 571,629. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. MariMed has a one year low of $0.06 and a one year high of $0.23. The stock has a market cap of $28.46 million, a price-to-earnings ratio of -2.38 and a beta of 1.30. The stock has a fifty day moving average price of $0.08 and a 200-day moving average price of $0.08.

MariMed (OTCMKTS:MRMD) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). MariMed had a negative net margin of 7.82% and a negative return on equity of 5.00%. The firm had revenue of $39.48 million for the quarter, compared to analyst estimates of $38.75 million. On average, equities analysts predict that MariMed will post -0.04 earnings per share for the current fiscal year.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.